Stockscreener 앱 받기
0.1683
17.04%
0.0245
Genprex Inc 주식(GNPX)의 최신 뉴스
Trend analysis for Genprex Inc. this weekEarnings Overview Summary & AI Driven Stock Movement Reports - Newser
Is Genprex Inc. forming a bottoming base2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser
Visual trend scoring systems applied to Genprex Inc.IPO Watch & Target Return Focused Picks - Newser
Genprex Inc. stock daily chart insights2025 Valuation Update & High Accuracy Trade Alerts - Newser
Leading vs lagging indicators on Genprex Inc. performanceQuarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
Earnings visualization tools for Genprex Inc.Earnings Risk Summary & Reliable Trade Execution Plans - Newser
Exit strategy if you’re trapped in Genprex Inc.Weekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers - Eastern Progress
What MACD signals say about Genprex Inc.July 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
Published on: 2025-08-19 14:58:20 - Newser
Has Genprex Inc. formed a bullish divergenceAnalyst Upgrade & Accurate Intraday Trade Tips - Newser
Predicting Genprex Inc. trend using moving averagesWeekly Trend Report & AI Enhanced Execution Alerts - Newser
Technical analysis overview for Genprex Inc. stockJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
News impact scoring models applied to Genprex Inc.Quarterly Growth Report & AI Forecast Swing Trade Picks - Newser
Statistical indicators supporting Genprex Inc.’s strengthMarket Risk Analysis & Long-Term Safe Investment Plans - Newser
How to manage a losing position in Genprex Inc.Portfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser
Genprex Secures Patent Allowances for Gene Therapy - MSN
How to build a custom watchlist for Genprex Inc.July 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Genprex Secures US, EU Patents for its Oncology Drug Reqorsa - Mexico Business News
Genprex receives notice of allowance for multiple patents for Reqorsa - TipRanks
Genprex Says US, EU Issue Patent Allowances for Reqorsa Combination Therapies - MarketScreener
Genprex receives patent allowances for cancer therapy combinations - Investing.com
Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa Gene Therapy in Combination with Immune Checkpoint Inhibitors to Treat Cancers - AInvest
Patent Protection Until 2037: Genprex Strengthens Reqorsa Cancer Therapy IP Portfolio Globally - Stock Titan
Comparing Genprex Inc. in custom built stock radarsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - Newser
Why Genprex Inc. stock attracts strong analyst attentionJuly 2025 Summary & Expert Verified Movement Alerts - thegnnews.com
Is Genprex Inc. stock reversal real or fakeEarnings Trend Report & Growth Focused Stock Pick Reports - Newser
Is Genprex Inc. stock suitable for long term investingWeekly Profit Summary & Scalable Portfolio Growth Ideas - thegnnews.com
Is Genprex Inc. stock bottoming outPortfolio Value Summary & Stepwise Swing Trade Plans - Newser
Will Genprex Inc. stock benefit from interest rate changesForecast Cut & Precise Buy Zone Identification - Newser
Genprex Inc. stock trend forecastTrade Volume Summary & Risk Controlled Stock Pick Alerts - Newser
Using fundamentals and technicals on Genprex Inc.Forecast Cut & AI Forecast Swing Trade Picks - Newser
Genprex Stockholders Approve Key Proposals at Annual Meeting - MSN
Price action breakdown for Genprex Inc.Market Performance Report & Weekly Stock Performance Updates - Newser
0.94%
1.72%
자본화:
|
볼륨(24시간):